Delight Medical & Wellness Center

Delight Medical & Wellness Center operates in Los Angeles, California, under the clinical direction of Dr. Payam Kerendian, providing peptide-based therapies with a primary focus on metabolic health and weight management. The clinic has established a specialized practice centered on GLP-1 receptor agonist peptides, specifically semaglutide and tirzepatide, which function by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. These peptides represent the clinic's core therapeutic approach for patients seeking medically supervised weight loss and metabolic optimization in the Los Angeles area.

The clinic's peptide protocols utilize semaglutide, a GLP-1 receptor agonist that mimics incretin hormones to reduce appetite and food intake, and tirzepatide, a dual GIP/GLP-1 receptor agonist that activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways for enhanced metabolic effects. Dr. Kerendian structures treatment plans with gradual dose titration to minimize gastrointestinal side effects while optimizing therapeutic response. Patients receive individualized dosing schedules based on their metabolic profile, weight loss goals, and tolerance to therapy. The clinic monitors patients through regular follow-up appointments that track weight changes, body composition shifts, energy levels, and any adverse reactions to peptide administration.

Dr. Payam Kerendian brings clinical expertise in functional and regenerative medicine to his practice at Delight Medical & Wellness Center, where he evaluates patients through comprehensive metabolic assessments before initiating peptide therapy. His approach includes baseline laboratory testing to assess thyroid function, insulin resistance markers, lipid panels, and hormonal status to identify underlying factors that may affect weight management outcomes. Dr. Kerendian adjusts peptide protocols based on individual patient response rather than applying standardized dosing, recognizing that factors such as baseline metabolic rate, medication interactions, and lifestyle variables influence treatment efficacy. The clinic's 5.0-star rating across 51 Google reviews reflects patient feedback regarding weight loss results, improved energy levels, and reduction in chronic pain symptoms that often accompany excess weight.

Patients beginning treatment at Delight Medical & Wellness Center undergo an initial consultation that includes medical history review, current medication assessment, and discussion of realistic weight loss timelines with peptide therapy. The clinic provides education on expected side effects such as nausea, constipation, or reduced appetite during the initial titration phase, along with dietary guidance to support peptide efficacy. Follow-up visits occur at intervals determined by the specific peptide protocol, typically every four to six weeks, during which Dr. Kerendian evaluates treatment response and makes necessary adjustments to dosing or supportive therapies. The clinic addresses not only weight reduction but also associated health improvements such as better glycemic control, reduced joint pain from decreased weight-bearing stress, and enhanced physical stamina reported by patients in their reviews.

Delight Medical & Wellness Center serves patients throughout Los Angeles County, offering a focused peptide therapy practice that prioritizes measurable outcomes in weight management and metabolic health. The clinic's concentration on semaglutide and tirzepatide allows Dr. Kerendian to maintain deep clinical experience with these specific peptides rather than diluting expertise across numerous treatment modalities. Patients seeking peptide therapy in Los Angeles find a practice that has refined its protocols through consistent application of GLP-1-based treatments, with systems in place for monitoring, dose adjustment, and management of the physiological changes that accompany significant weight loss. The clinic's location in Los Angeles provides access to patients across the greater metropolitan area who require ongoing medical supervision for peptide-based weight management programs.